Diabetes Update: Where We Are With GLP-1 Receptor Agonists and SGLT2 Inhibitors

This course reviews advancements in diabetes treatment with a focus on GLP-1 receptor agonists and SGLT2 inhibitors. It can be taken by anyone interested in the topic but offers continuing education (CE) credit for healthcare practitioners in the United States, including pharmacists and nursing professionals. Medications used to manage type 2 diabetes have evolved significantly in recent years, with new drug classes and updates to existing therapies. This course brings together clinical trial data on GLP-1 agonists and SGLT2 inhibitors and offers insights into their indications, side effects, and place in therapy. Participants will learn to tailor diabetes treatment strategies to individual patient needs, review the latest American Diabetes Association and American Endocrine Society guidelines, and assess the advantages and disadvantages of these treatments, particularly for patients with comorbidities.